You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

primary immune deficiencies

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer

Completed
  • Cancer Treated With Immune-checkpoint Inhibitors
  • Immune checkpoint inhibitor
  • Bordeaux, France
    Institut Bergonié, Comprehensive Cancer Center
Dec 6, 2021

Lesion in Body Region, CNS Lesion Trial in Japan (Gadopiclenol, Comparator)

Recruiting
  • Lesion in Body Region
  • CNS Lesion
  • Aichi, Japan
  • +27 more
Aug 28, 2023

Continuous Glucose Monitoring, Colorectal Cancer Trial in Gdansk (CGM (FreeStyle Libre 3))

Recruiting
  • Continuous Glucose Monitoring
  • Colorectal Cancer
  • CGM (FreeStyle Libre 3)
  • Gdańsk, Pomeranian, Poland
    UCC Division of Oncological, Transplant and General Surgery
Aug 30, 2023

Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Afrezza
  • +3 more
  • (no location specified)
Jun 6, 2023

Amyotrophic Lateral Sclerosis Trial in Worldwide (BIIB105, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • La Jolla, California
  • +11 more
Aug 11, 2022

Cpc-PH Due to HFpEF (Combined Post-capillary and Pre-capillary Pulmonary Hypertension Due to Heart Failure With Preserved

Recruiting
  • Hypertension, Pulmonary
  • Sotatercept 0.3 mg/kg
  • +2 more
  • Phoenix, Arizona
  • +68 more
Jan 20, 2023

Polyps of Colon, Recurrence, Local Tumor Trial in Nijmegen (Snare tip soft coagulation)

Recruiting
  • Polyps of Colon
  • Recurrence, Local Neoplasm
  • Snare tip soft coagulation
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
May 31, 2022

Autism Spectrum Disorder, Catatonia Trial in Nashville (Continuous Theta Burst in Transcranial Magnetic Stimulation)

Recruiting
  • Autism Spectrum Disorder
  • Catatonia
  • Continuous Theta Burst in Transcranial Magnetic Stimulation
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 23, 2023

Hepatocellular Carcinoma Trial in Guangzhou (PD-1 mAb, Radiofequencey or microwave ablation)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 monoclonal antibody
  • Radiofequencey or microwave ablation
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 4, 2022

Squamous Cell Carcinoma in Fanconi Anemia

Recruiting
  • Fanconi Anemia
  • Inherited Bone Marrow Failure Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Analgesia Trial (Dural Puncture Epidural (DPE), Standart Epidural)

    Recruiting
    • Analgesia
    • Dural Puncture Epidural (DPE)
    • Standart Epidural
    • Erzurum, Turkey
      Atatürk University
    Dec 1, 2022

    Trauma Trial in India (Audit filters)

    Enrolling by invitation
    • Trauma
    • Audit filters
    • Bengaluru, India
    • +3 more
    Sep 1, 2021

    Healthy Volunteer Study, Opioid-use Disorder Trial in Melbourne (KNX100)

    Recruiting
    • Healthy Volunteer Study
    • Opioid-use Disorder
    • Melbourne, Victoria, Australia
      Nucleus Network
    Apr 12, 2022

    Immunoglobulin DeficiencyTreatable Cause of Fatigue in Multiple

    Recruiting
    • Hypogammaglobulinemia
    • +2 more
    • Laboratory test
    • Bern, BE, Switzerland
      University Hospital of Bern Inselspital
    Sep 26, 2022

    Post-operative Pain Management, Hip Fracture Surgery Trial in Lahore (PENG block, FICB Block)

    Completed
    • Post-operative Pain Management
    • Hip Fracture Surgery
    • PENG block
    • FICB Block
    • Lahore, Pakistan
      Pain Medicine Department
    Mar 30, 2023

    Obese Trial in Lahore (Black Seed ( Nigella Sativa), Cumin Seed (Cuminum Cyminum))

    Recruiting
    • Obese
    • Black Seed ( Nigella Sativa)
    • Cumin Seed (Cuminum Cyminum)
    • Lahore, Punjab, Pakistan
      Sehat Medical Complex, Lahore
    Mar 14, 2023

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

    Recruiting
    • Deleterious BRCA1 Gene Mutation
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 23, 2022

    Diabetes, Type 2, Obesity Trial (endomina®)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Obesity
    • endomina®
    • (no location specified)
    Aug 23, 2022

    Acute Blood Loss Trial in United States (Cold Stored Platelets, Room Temperature Platelets)

    Recruiting
    • Acute Blood Loss
    • Cold Stored Platelets
    • Room Temperature Platelets
    • Los Angeles, California
    • +13 more
    Aug 24, 2022

    Embolism and Thrombosis Trial in Seoul (Rivaroxaban 18mg Oral Tablet, Rivaroxaban 20 MG Oral Tablet)

    Completed
    • Embolism and Thrombosis
    • Rivaroxaban 18mg Oral Tablet
    • Rivaroxaban 20 MG Oral Tablet
    • Seoul, Korea, Republic of
      H+ Yangji Hospital
    Feb 20, 2022

    Anemia Trial in Australia (BGE-117, Placebo)

    Withdrawn
    • Anemia
    • Blacktown, New South Wales, Australia
    • +12 more
    Apr 29, 2022

    Aging, Healthy Aging Trial in San Diego (Strawberry, Placebo group)

    Completed
    • Aging
    • Healthy Aging
    • Strawberry
    • Placebo group
    • San Diego, California
      Shirin Hooshmand
    May 3, 2022

    NECROtizing Soft Tissue Infections and Their Scoring System

    Recruiting
    • Necrosis
    • Necrotizing soft tissue infections (NSTIs)
    • Dallas, Texas
      Methodist Dallas Medical Center
    Feb 3, 2022

    Hepatocellular Carcinoma, Metastatic Cancer Trial in Makati City, Pasig City, Quezon City (GEN2 (HSV-Thymidine Kinase-m2 and

    Recruiting
    • Hepatocellular Carcinoma
    • Metastatic Cancer
    • GEN2 (HSV-Thymidine Kinase-m2 and hGM-CSF Genes)
    • Makati City, Philippines
    • +3 more
    Mar 14, 2022

    Primary Aesthetic Breast Augmentation: Comparative Study Between

    Recruiting
    • Breast Implants
      • Strasbourg, France
        Service de Chirurgie Plastique, Reconstructrice et Esthétique -
      Nov 22, 2023